ferrous gluconate has been researched along with Anemia, Iron-Deficiency in 25 studies
*Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.00) | 18.7374 |
1990's | 4 (16.00) | 18.2507 |
2000's | 12 (48.00) | 29.6817 |
2010's | 6 (24.00) | 24.3611 |
2020's | 2 (8.00) | 2.80 |
Authors | Studies |
---|---|
Bertoni, E; Boscarol, G; Capolsini, I; Casciana, ML; Caselli, D; Colombatti, R; Condorelli, A; Corti, P; Facchini, E; Fasoli, S; Giona, F; Giordano, P; Guardabasso, V; Marinoni, M; Maruzzi, M; Notarangelo, LD; Pizzato, C; Ramenghi, U; Romano, F; Russo, G; Sainati, L; Samperi, P; Tucci, F | 1 |
Aloni, A; Beverina, I; Brando, B; Gatti, F; Varalli, L | 1 |
Bialkowski, W; Birch, R; Bryant, BJ; Cable, R; D'Andrea, P; Kiss, JE; Mast, AE; Spencer, BR; Wright, DJ | 1 |
Costabile, L; D'Anna, R; Filati, P; Laganà, AS; Noventa, M; Vitagliano, A | 1 |
AlHusban, M; Awidi, A; Awidi, M; Bawaneh, H; Zureigat, H | 1 |
Cuevas-Nasu, L; Jiménez-Aguilar, A; Mundo-Rosas, V; Rivera-Dommarco, JA; Shamah-Levy, T; Villalpando, S | 1 |
Baloum, M; Haj Yehia, M; Jaber, L; Rigler, S; Tamary, H; Taya, A; Tebi, F; Yaniv, I | 1 |
Cheng, S; Coppol, E; Kaakeh, Y; Shelly, J; Shepler, B | 1 |
Cancelo-Hidalgo, MJ; Castelo-Branco, C; Ciria-Recasens, M; Haya-Palazuelos, J; Manasanch, J; Palacios, S; Pérez-Edo, L | 1 |
ANSELMO, A | 1 |
Kiesewetter, H; Radtke, H; Röcker, L; Salama, A; Tegtmeier, J | 2 |
Ivanov, S; Sigridov, I | 1 |
Maling, TJ; Weatherall, M | 1 |
Ivancheva, Kh; Milchev, N; Paskaleva, V | 1 |
Grant, CC; Taua, N; Thompson, JM; Wall, CR; Wilson, C | 1 |
Kagansky, M; Kagansky, N; Levy, S; Mashiah, T; Mechnick, L; Namir, M; Rimon, E | 1 |
Barrado, A; Boccio, J; Janjetic, M; Orlandini, J; Torti, H; Urriza, R; Weill, R | 1 |
Lara, Y; Monterrubio, E; Rivera, JA; Shamah, T; Villalpando, S | 1 |
Birgegård, G; Hedenus, M | 1 |
Branconi, F; Casparis, D; Del Carlo, P; Gafforio, L; Grossi, A; Merante, D | 1 |
Hörl, WH; Sunder-Plassmann, G | 1 |
Huang, MH; Huang, ZQ; Pan, LJ; Wu, B; Wu, GT; You, KS; Zhang, C; Zhao, ZQ | 1 |
Christou, NV; MacLean, LD; Rhode, BM; Shustik, C | 1 |
Bailie, GR; Johnson, CA; Mason, NA | 1 |
4 review(s) available for ferrous gluconate and Anemia, Iron-Deficiency
Article | Year |
---|---|
A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Clinical Trials as Topic; Ferric Compounds; Ferric Oxide, Saccharated; Ferrosoferric Oxide; Ferrous Compounds; Glucaric Acid; Humans; Iron-Dextran Complex; Renal Dialysis; Renal Insufficiency, Chronic | 2011 |
Tolerability of different oral iron supplements: a systematic review.
Topics: Anemia, Iron-Deficiency; Dietary Supplements; Ferric Compounds; Ferrous Compounds; Glycine; Humans; Metalloproteins; Succinates | 2013 |
The role of iron supplementation during epoietin treatment for cancer-related anemia.
Topics: Administration, Oral; Anemia, Iron-Deficiency; Drug Administration Schedule; Erythropoiesis; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Hematinics; Humans; Infusions, Intravenous; Iron Compounds; Iron-Dextran Complex; Iron, Dietary; Maltose; Neoplasms; Randomized Controlled Trials as Topic | 2009 |
Safety aspects of parenteral iron in patients with end-stage renal disease.
Topics: Anemia, Iron-Deficiency; Citric Acid; Drug Combinations; Drug Monitoring; Erythropoietin; Ferric Compounds; Ferric Oxide, Saccharated; Ferrous Compounds; Glucaric Acid; Humans; Infusions, Intravenous; Injections, Intravenous; Iron Compounds; Iron Overload; Iron-Dextran Complex; Kidney Failure, Chronic; Sorbitol | 1997 |
12 trial(s) available for ferrous gluconate and Anemia, Iron-Deficiency
Article | Year |
---|---|
Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica).
Topics: Administration, Oral; Adolescent; Anemia, Iron-Deficiency; Child; Child, Preschool; Female; Ferrous Compounds; Humans; Infant; Iron; Male; Prospective Studies | 2020 |
Effects of micronised dispersible ferric pyrophosphate combined with alpha-lactalbumin in pregnant women affected by iron deficiency anemia: results from a prospective, double-blind, randomized controlled trial.
Topics: Adult; Anemia, Iron-Deficiency; Diphosphates; Double-Blind Method; Drug Compounding; Female; Ferrous Compounds; Gestational Age; Humans; Iron; Lactalbumin; Pregnancy; Prospective Studies; Young Adult | 2018 |
Ferrous gluconate and ferrous sulfate added to a complementary food distributed by the Mexican nutrition program Oportunidades have a comparable efficacy to reduce iron deficiency in toddlers.
Topics: Anemia, Iron-Deficiency; Child, Preschool; Dietary Supplements; Female; Ferrous Compounds; Food Additives; Hematinics; Hemoglobins; Humans; Infant; Infant Food; Iron; Male; Mexico; Multivariate Analysis; Prevalence; Registries | 2008 |
Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy.
Topics: Anemia, Iron-Deficiency; Erythrocyte Indices; Female; Ferric Compounds; Ferritins; Ferrous Compounds; Hematinics; Hematocrit; Hemoglobins; Humans; Infant; Infant, Newborn; Iron; Male; Prospective Studies; Transferrin | 2010 |
Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study.
Topics: Adult; Aged; Anemia, Iron-Deficiency; Blood Donors; Dietary Supplements; Digestive System; Dose-Response Relationship, Drug; Double-Blind Method; Female; Ferritins; Ferrous Compounds; Humans; Iron; Iron Deficiencies; Male; Middle Aged; Placebos; Receptors, Transferrin; Regression Analysis; Sex Factors; Treatment Refusal | 2004 |
Oral iron therapy for anaemia after orthopaedic surgery: randomized clinical trial.
Topics: Administration, Oral; Aged; Anemia, Iron-Deficiency; Arthroplasty, Replacement; Double-Blind Method; Female; Ferrous Compounds; Follow-Up Studies; Hematinics; Hemoglobins; Humans; Male; Middle Aged; Postoperative Care | 2004 |
[Treatment of iron-deficiency anaemia with ferrous gluconate].
Topics: Adult; Aged; Anemia, Iron-Deficiency; Drug Combinations; Erythrocyte Count; Female; Ferrous Compounds; Gluconates; Hemoglobins; Humans; Iron; Middle Aged; Treatment Outcome | 2004 |
Milk versus medicine for the treatment of iron deficiency anaemia in hospitalised infants.
Topics: Anemia, Iron-Deficiency; Animals; Dietary Supplements; Female; Ferrous Compounds; Follow-Up Studies; Food, Fortified; Humans; Infant; Iron; Iron, Dietary; Male; Milk; Nutritional Status; Prospective Studies | 2005 |
Are we giving too much iron? Low-dose iron therapy is effective in octogenarians.
Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Antioxidants; Calcium Citrate; Dose-Response Relationship, Drug; Female; Ferritins; Ferrous Compounds; Hemoglobins; Humans; Iron; Male; Reticulocyte Count | 2005 |
Fortifying milk with ferrous gluconate and zinc oxide in a public nutrition program reduced the prevalence of anemia in toddlers.
Topics: Anemia, Iron-Deficiency; Animals; Ascorbic Acid; C-Reactive Protein; Child, Preschool; Female; Ferritins; Ferrous Compounds; Food, Fortified; Hemoglobins; Humans; Infant; Linear Models; Male; Mexico; Milk; Nutritional Status; Receptors, Transferrin; Zinc Oxide | 2006 |
[Effectiveness and tolerability of oral liquid ferrous gluconate in iron-deficiency anemia in pregnancy and in the immediate post-partum period: comparison with other liquid or solid formulations containing bivalent or trivalent iron].
Topics: Administration, Oral; Adult; Anemia, Iron-Deficiency; Erythrocytes; Female; Ferrous Compounds; Hematocrit; Hemoglobins; Humans; Iron; Pregnancy; Pregnancy Complications, Hematologic; Puerperal Disorders; Solutions; Tablets; Treatment Outcome | 1996 |
Iron absorption and therapy after gastric bypass.
Topics: Adult; Anemia, Iron-Deficiency; Ascorbic Acid; Dose-Response Relationship, Drug; Drug Interactions; Female; Ferrous Compounds; Follow-Up Studies; Gastric Bypass; Humans; Iron; Male; Middle Aged; Treatment Outcome | 1999 |
9 other study(ies) available for ferrous gluconate and Anemia, Iron-Deficiency
Article | Year |
---|---|
Attitude changes in prescribing intravenous iron supplementation in different settings at a hospital consortium in Italy.
Topics: Administration, Intravenous; Anemia, Iron-Deficiency; Costs and Cost Analysis; Drug Prescriptions; Female; Ferric Compounds; Ferrous Compounds; Humans; Male; Maltose | 2021 |
Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy.
Topics: Anemia, Iron-Deficiency; Female; Ferrous Compounds; Humans; Iron; Male; Phlebotomy; Postoperative Complications | 2017 |
Contributing factors to iron deficiency anemia in women in Jordan: A single-center cross-sectional study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Cross-Sectional Studies; Female; Ferrous Compounds; Follow-Up Studies; Humans; Jordan; Middle Aged; Risk Factors; Treatment Outcome; Young Adult | 2018 |
[Ferrous gluconate in therapy of iron deficiency anemia].
Topics: Anemia; Anemia, Hypochromic; Anemia, Iron-Deficiency; Blood; Ferrous Compounds; Hematologic Diseases; Humans; Iron | 1953 |
[Tot'hema--alternative in the treatment of iron deficiency and iron deficiency anemia].
Topics: Anemia, Iron-Deficiency; Drug Combinations; Female; Ferrous Compounds; Gluconates; Hemoglobins; Humans; Iron Deficiencies; Pregnancy; Pregnancy Complications, Hematologic; Treatment Outcome | 2004 |
Compensating for iron loss in regular blood donors using ferrous gluconate and ascorbic acid.
Topics: Adolescent; Adult; Aged; Anemia, Iron-Deficiency; Ascorbic Acid; Blood Donors; Double-Blind Method; Female; Ferritins; Ferrous Compounds; Hematinics; Humans; Male; Middle Aged; Receptors, Transferrin; Sex Factors; Solubility; Time Factors | 2005 |
Iron bioavailability from fortified petit suisse cheese determined by the prophylactic-preventive method.
Topics: Analysis of Variance; Anemia, Iron-Deficiency; Animals; Biological Availability; Body Weight; Cheese; Ferrous Compounds; Glycine; Hemoglobins; Iron; Iron, Dietary; Male; Rats; Rats, Sprague-Dawley | 2006 |
[Effect of hemin in treating hemorrhagic anemia and toxicity].
Topics: Anemia, Iron-Deficiency; Animals; Female; Ferrous Compounds; Hemin; Hemorrhage; Male; Mice; Mice, Inbred ICR; Random Allocation; Rats; Rats, Sprague-Dawley | 1996 |
Intravenous iron products.
Topics: Anemia, Iron-Deficiency; Bias; Drug Monitoring; Ferrous Compounds; Humans; Iron; Kidney Failure, Chronic; Reproducibility of Results; Transferrin | 2000 |